Bioinformatics analysis of TCGA data shows IGFBP-3 mRNA levels are significantly lower in breast, liver and cervical cancers, while slightly increased in colorectal cancer (CRC) compared to normal tissue. This evidence concerns the gene IGFBP3 and cervical carcinoma.